Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder
Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder
About this item
Full title
Author / Creator
Publisher
Cheshire: Springer Healthcare
Journal title
Language
English
Formats
Publication information
Publisher
Cheshire: Springer Healthcare
Subjects
More information
Scope and Contents
Contents
Background
Pharmacologic treatments are available to treat insomnia, a common and burdensome sleep disorder, but may be contraindicated in older adults who are prone to side effects from sleep-promoting drugs. These analyses of sleep diary data from Study E2006-G000-303 (Study 303) investigated the benefits of lemborexant 5 mg (LEM5) and 10 mg (...
Alternative Titles
Full title
Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_23ca3d2e802c4505a3c5dd1335916d83
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_23ca3d2e802c4505a3c5dd1335916d83
Other Identifiers
ISSN
2193-8253
E-ISSN
2193-6536
DOI
10.1007/s40120-024-00622-9
